Structural Bioinformatics, ChemNavigator Enter Drug-Discovery Pact | GenomeWeb

NEW YORK, Sept. 5 – Structural Bioinformatics and ChemNavigator have agreed to combine their technologies in order to identify novel drug candidates, SBI announced on Wednesday.

According to the terms of the agreement, SBI and its customers will have access to ChemNavigator’s iResearch System, a database of chemical structures for 2 million drug-like compounds. This information can then be screened against SBI’s own drug-target database of three-dimensional protein structures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.